Liquid Biopsy Diagnostics
Early Cancer Detection (Initial focus: Brain Tumors)
Research/Pre-clinicalActive
Key Facts
Indication
Early Cancer Detection (Initial focus: Brain Tumors)
Phase
Research/Pre-clinical
Status
Active
Company
About iNanoBio
iNanoBio is a private, pre-revenue biotech company founded in 2018 and based in Cambridge, Massachusetts (with a noted Arizona connection). It leverages a proprietary FDEC FET nano sensor technology to target two major applications: a next-generation, CMOS-based 3D nanopore genome sequencer and liquid biopsy diagnostics for early cancer detection. The company is bolstered by a high-profile scientific advisory board, including pioneers like Dr. George Church and Dr. Chenming Hu, and is actively presenting at industry conferences to advance its technology and seek partnerships.
View full company profile